Allergy drug improves function in patients with chronic injury from multiple sclerosis
In a remarkably rapid translation of laboratory research findings into a treatment with the potential to benefit patients, UC San Francisco scientists have successfully completed a Phase II clinical trial showing that an ...
Oct 11, 2017
0
1049